108 related articles for article (PubMed ID: 18650241)
1. Naming names: is there an (unbiased) doctor in the house?
Lenzer J; Brownlee S
BMJ; 2008 Jul; 337():a930. PubMed ID: 18650241
[No Abstract] [Full Text] [Related]
2. Developing unbiased diagnostic and treatment guidelines in psychiatry.
Cosgrove L; Bursztajn HJ; Krimsky S
N Engl J Med; 2009 May; 360(19):2035-6. PubMed ID: 19420379
[No Abstract] [Full Text] [Related]
3. Philanthropy, ethics, and leadership in academic psychiatry.
Roberts LW; Coverdale J; Louie AK
Acad Psychiatry; 2006; 30(4):269-72. PubMed ID: 16908601
[No Abstract] [Full Text] [Related]
4. Big pharma and American psychiatry.
Sharfstein SS
J Nerv Ment Dis; 2008 Apr; 196(4):265-6. PubMed ID: 18414119
[No Abstract] [Full Text] [Related]
5. The long arm of financial conflicts of interest: extensions into lined pockets, research and review, and the United States Senate.
Rivkees SA
J Pediatr Endocrinol Metab; 2008 Jul; 21(7):607-9. PubMed ID: 18780592
[No Abstract] [Full Text] [Related]
6. US psychiatrist is fired from radio programme for not disclosing drug company ties.
Tanne JH
BMJ; 2008 Dec; 337():a2934. PubMed ID: 19066260
[No Abstract] [Full Text] [Related]
7. Pharma payment probe widens its net.
Wadman M
Nature; 2008 Oct; 455(7216):1017. PubMed ID: 18948916
[No Abstract] [Full Text] [Related]
8. [Conflict of interest viewed from over-sea reports regarding relationship between clinical psychiatry and drug industry].
Senba J
Seishin Shinkeigaku Zasshi; 2010; 112(11):1124-9. PubMed ID: 21351692
[No Abstract] [Full Text] [Related]
9. Key opinion leaders in psychiatry: a conflicted pathway to career advancement.
Jureidini J
Aust N Z J Psychiatry; 2012 Jun; 46(6):495-7. PubMed ID: 22679201
[No Abstract] [Full Text] [Related]
10. Who pays the piper?
Friedli L
Ment Health Today; 2003 Nov; ():8-9. PubMed ID: 14689593
[No Abstract] [Full Text] [Related]
11. Ball or aerosol? Sin, soap and the pharmaceutical industry.
Ratcliff E
Australas Psychiatry; 2013 Feb; 21(1):27-31. PubMed ID: 23344801
[TBL] [Abstract][Full Text] [Related]
12. Supping with the devil? The dangers of liaisons between pharma and our profession.
Boyce P; Malhi GS
Aust N Z J Psychiatry; 2012 Jun; 46(6):493-4. PubMed ID: 22679200
[No Abstract] [Full Text] [Related]
13. [Code of conduct for psychiatrist - established on behalf of the Austrian Society for Psychiatry and Psychotherapy].
Hinterhuber vH; Lehofer M; Ofner H; Stuppäck C;
Neuropsychiatr; 2009; 23(4):263-6. PubMed ID: 19909698
[No Abstract] [Full Text] [Related]
14. How to manage conflicts of interest with industry?
Schowalter JE
Int Rev Psychiatry; 2008 Apr; 20(2):127-33. PubMed ID: 18386202
[TBL] [Abstract][Full Text] [Related]
15. Trainees and collaborations with industry.
Brewer S
Am J Psychiatry; 2010 Sep; 167(9):1127; author reply 1127. PubMed ID: 20826861
[No Abstract] [Full Text] [Related]
16. Doctor, do you have a minute? The dilemma posed by physician interaction with the pharmaceutical industry.
Quan SF
J Clin Sleep Med; 2007 Jun; 3(4):345-6. PubMed ID: 17694720
[No Abstract] [Full Text] [Related]
17. [Relationship of psychiatrists to the pharmaceutical companies--part of, or the solution to, the problem].
Insel TR
Lege Artis Med; 2010 Sep; 20(9):630-1. PubMed ID: 21469310
[No Abstract] [Full Text] [Related]
18. Letting the sunshine in on doctor-pharma relationships.
Jack A
BMJ; 2011 Oct; 343():d6459. PubMed ID: 21990283
[No Abstract] [Full Text] [Related]
19. Psychiatry has effectively become a commodity that is being sold to the drug industry.
Timimi S
Ment Health Today; 2005 Jun; ():21. PubMed ID: 15999409
[No Abstract] [Full Text] [Related]
20. Conflict of interest in Psychiatry.
Bernardo M; Martín-Carrasco M
Rev Psiquiatr Salud Ment (Engl Ed); 2019; 12(4):201-206. PubMed ID: 31255516
[No Abstract] [Full Text] [Related]
[Next] [New Search]
